Bioactivity guided investigation of the DCM: MeOH (1:1) extract from the rhizomes of Alpinia galanga led to the isolation of phenylpropanoids (1-9) and their structures were established by 1 H NMR, 13 C NMR, IR and LC-MS/MS. These compounds have been evaluated for their in vitro anticancer activity against the human cancer cell lines A549 (lung cancer), Colo-205 (colon cancer), A431 (skin cancer), NCI H460 (lung cancer), PC-3 (prostate cancer), and HT-29 (colon cancer). Compounds 4 and 9 showed potent anticancer activity (ranging from 1.3-19.7 µg/mL) against all the tested cancer cell lines. In addition, an asymmetric synthesis of acetoxychavicol acetate (1) and trans-p-coumaryl alcohol (4) has been accomplished in six steps starting from readily available p-hydroxybenzaldehyde for the first time. Grignard reaction and Sharpless kinetic resolution reactions were utilized as the key steps to install the basic core.
Cancer is one of the most serious threats against human health in the world. Over the past few decades, extensive research has led to the development of a plethora of chemotherapeutic agents; however, none of these agents are capable of completely eliminating cancer [1] . The limitations of current anticancer drugs, increased incidence, and rapid development of drug resistance [2] have highlighted the need for the discovery of new anticancer agents, preferably with novel mechanisms of action. In this respect, the plant kingdom is now recognized as a source of promising chemopreventive agents [3] . They can be viewed as evolved privileged structures with potent biological activities and biologically pre-validated leads which have played a highly significant role in the discovery and development of new drugs for the treatment of human diseases. This is especially true in the cancer field, where about half the drugs are of natural origin and include two of the most important agents, taxol and taxotere. [4] As part of pharmacological-phytochemical integrated studies of medicinal plants from the Indian flora [5], we are investigating chemical constituents of plants belonging to the Zingiberaceae family, as well as their cytotoxic activity [6] . In a continuing investigation, phytochemical studies were carried out on Alpinia galanga, a tree that grows commonly in the southern part of India, where it is popularly known as Kulanjan. This plant is reported to exhibit antileishmanial [7] , antifungal [8] , hypoglycemic [9] , gastroprotective [10] , and anticancer activities [11] .
As part of an ongoing effort to discover potential leads from Indian medicinal plants for development of anticancer therapeutics, we observed potent, significant, cytotoxic activity in the DCM: methanol (1:1) extract of Alpania galanga (L.) Willd. The active extract was subjected to bioassay-guided separation that resulted in the isolation of phenyl propanoid derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) .
Herein, we report the isolation, structure elucidation and cytotoxicity evaluation of phenylpropanoids (1) (2) (3) (4) (5) (6) (7) (8) (9) , along with the synthesis of trans-p-coumaryl alcohol (4) and acetoxychavicol acetate (1) by using the Grignard reaction and Sharpless kinetic resolution as the key steps. In addition, we also prepared a series of ester analogues by using different acids and assessed them for their cytotoxic activity. To the best of our knowledge, this is the first report on the asymmetric synthesis of phenylpropanoid ester derivatives The concentrated DCM: MeOH (1:1) extract was chromatographed on silica gel, and the resultant fractions were subjected to bioassay for cytotoxic activity against a panel of cancer cell lines. Repeated column chromatography of the bioactive fractions resulted in the isolation of nine compounds. The compounds were identified as (1'S) -1'-acetoxychavicol acetate (1) [12, 13] , p-coumaryl diacetate (2) [14] , (1'S)-1'-acetoxyeugenol acetate (3) [12, 13] , trans-p-coumaryl alcohol (4) [10] , p-hydroxybenzaldehyde (5) [14] , 1'S-1'-hydroxychavicol acetate (6) [10] , p-methyl benzaldehyde (7) , trans-p-hydroxycinnamyl acetate (8) [10] , and trans-o-hydroxycinnamaldehyde (9) from 1 H and 13 C NMR data comparison with those reported in literature.
The isolated phenylpropanoids (1-9) were evaluated for their anticancer activity against a panel of six human cancer cell lines, A549 (lung cancer), Colo-205 (colon cancer, A431 (skin cancer), NCI H460 (lung cancer), PC-3 (prostate cancer), and HT-29 (colon cancer) by employing MTT assay [6] . Doxorubicin was used as the reference drug. The results, summarized in Table 1 , are expressed as IC 50 values. The in vitro screening results revealed that these compounds exhibit promising anticancer activity with IC 50 values ranging from 1.9 to 13.5 µg/mL against different cancer cell lines. The most active compounds, 4 and 9, gave IC 50 values ranging from 1.8-13.4 and 5.6-19.9 µg/mL, respectively. 
Synthesis of 4 and its derivatives:
Prompted by the biological properties of 4, the present study was devised to synthesize new derivatives by using the above lead compounds and investigating their cytotoxic properties. As shown in Scheme 1, the synthesis began with 4-hydroxy benzaldehyde 11, which was converted to its tosyl ester [15] 12 in 71% yield. Grignard reaction of 12 in the presence of vinyl magnesium bromide furnished racemic alcohol 13, the tosyl deprotection [15] of which, in the presence of methanol under reflux conditions, yields 4-hydroxy phenyl methyl ether phenylpropanoid core 4 via allylic rearrangement [16] . Using this compound as a starting material, we made several derivatives by esterifying [17] with aliphatic and aromatic acids in the presence of EDCI and DMAP pyridine to afford corresponding esters 15a-h.
. 
Stereoselective synthesis of 22a-c and 21:
Further, we have also extended our efforts to the synthesis of 21 and 22a-c. As shown in Scheme 2. Synthesis began with 4-hydroxy benzaldehyde (11) , which was converted to its TBDMS ether 16 [16] in 91% yield. Grignard reaction [16] of 16 with vinyl magnesium bromide furnished racemic alcohol 17, which was resolved by Sharpless kinetic resolution [18] to give the required S alcohol 18 and epoxide 19. The deprotection of the TBDMS group [16] in 17 and 18 with TBAF afforded phenylpropanoid cores 20 and 10. Finally, the phenylpropanoid core 20 was coupled [17] with acetic acid in the presence of TEA to afford 21 in 71% yield.
Selective acetylation of the phenolic hydroxyl of 10 leading to monoacetate 22a-c was accomplished with acetic acid and propanoic acid in the presence of triethylamine to afford 22a (70%) and 22b (73%), and with tiglic acid in the presence of EDCI and DMAP in pyridine to afford 22c (74%).
Biological activity:
All the synthesized derivatives were tested in vitro against a panel of cancer cell lines [6] . To our disappointment, introduction of the ester moiety at C-4 (phenolic OH) was not a good site to modify since none of the derivatives showed any activity. The lack of activity of the synthetic derivatives cannot be explained simply by reaction mechanism. Either the binding affinity or selectivity of the structures of the compounds to the reactive site of the target (enzyme) must play a key role. At this point, it may be that the hydroxyl group remains the optimum functional group to exhibit activity. These early conclusions point the way for further more focused studies aimed at the design and synthesis of more potent and selective analogues as biological tools and potential drug candidates.
Conclusion:
In conclusion, we have isolated nine phenylpropanoid derivatives and their cytotoxic properties were investigated. The results of our study indicated that (E)-3-methoxyprop-1-enyl) phenol (4) showed potent activity comparable with the standard drug doxorubicin. Based on these results, we also synthesized (1'S) -1'-acetoxychavicol acetate (1) and trans-p-coumaryl alcohol (4), and their derivatives using the Grignard and Sharpless asymmetric reactions as key steps.
Experimental
General: Melting points were recorded on a Fisher Johns apparatus and are uncorrected. FABMS were obtained from a VG Auto spec-M instrument, IR spectra from a Nicolet spectrometer, and 1 H NMR 
Extraction and isolation:
The active chloroform extract (1 g) of Alpinia galanga was fractionated by CC with ethyl acetaten-hexane. Initially, the column was started with 1% ethyl acetate: n-hexane, and then with increasing polarity of solvent (2%, 4%, 8%, 10%, 15%, 20%, 25%, and 30%); 9 compounds were obtained: (S)-4-(1-acetoxyallyl)phenyl acetate (1) (20 mg) [12, 13] , (E)-3-(4acetoxyphenyl)allyl acetate (2) (25 mg) [14] , (S)-1-(4-acetoxy-3methoxyphenyl)allyl acetate (3) (20 mg) [12, 13] , (E)-4-(3methoxyprop-1-en-1-yl)phenol (4) (20 mg) [10] (50 mg), 4hydroxybenzaldehyde (5) (15 mg) [14] , (S)-4-(1-hydroxyallyl)phenyl acetate (6) (18 mg) [10] , 4-methylbenzaldehyde (10 mg) (7) , (E)-3-(4-hydroxyphenyl)allyl acetate (8) (22 mg) [10] , and (E)-3-(2-hydroxyphenyl)acrylaldehyde (26 mg) (9).
4-(1-Hydroxyallyl) phenyl 4-methylbenzenesulfonate (12):
The 4-hydroxybenzaldehyde (11) (10 g, 80.96 mmol) was dissolved in DCM (100 mL). To the stirred solution, TEA (8.27g, 81.96 mmol) was added at 0°C, followed by p-toluene sulfonyl chloride (15.57g, 81.96 mmol). Then the reaction temperature was raised to 25°C and stirred for 2 h. The reaction was diluted with water (50 mL) and the layers separated. The organic layer was further washed with water (2×30 mL), followed by saturated aq. NaHCO 3 (30 mL) and brine (30 mL). The combined organic layers were dried with Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude residue was purified by flash chromatography using Hex: EA (85:15) to give tosylated p-hydroxybenzaldehyde (12) .
White crystalline solid. Yield: 71%. 1 
4-(1-Hydroxyallyl)phenyl 4-methylbenzenesulfonate (13):
To a solution of 12 (7 g, 25.37 mmole) in dry THF (70 mL) under a nitrogen atmosphere at 0°C was added, dropwise, 30.43 mL of a 1M solution of vinyl magnesium bromide in THF. The reaction was stirred for 45 min. at r.t. After completion (TLC), the reaction was quenched with saturated NH 4 Cl solution at 0°C and extracted with ethyl acetate (2×50 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 and the solvent was evaporated to dryness. The crude product was purified by CC using Hex: EA (90:10) as eluent to give vinyl alcohol 13. Light yellow viscous liquid.
Yield: 60%. 1 4-(3-Methoxyprop-1-en-1-yl) phenol (4) : To a stirred solution of vinyl alcohol 13 (0.1 g, 0.3486 mmol) in methanol (bottle grade 5 mL) was added K 2 CO 3 (0.24 g, 1.745 mmol), and the mixture was heated at reflux for 2 h. The reaction mixture was cooled to r.t., and checked by TLC. The mixture was acidified with 1 N HCl until the pH of the mixture reached 2. The combined aq/methanol solution was extracted with ethyl acetate (2×15 mL). The organic extracts were washed with brine (10 mL), dried with Na 2 SO 4, filtered and concentrated in vacuo. The crude product was purified by CC using Hex: EA (80:20) to give 4.
(E)-
Light yellow viscous liquid. Yield: 60%. 1 
General procedure for the preparation of compounds 15a-15h:
EDCI (140 mg, 0.35 mmol) and DMAP (4.45 mg, 0.036 mmol) were added to a solution of tiglic acid in pyridine at 0°C. The reaction mixture was stirred at room temperature to dissolve the EDCI completely. After complete dissolution, a solution of compound 4 (0.04 g, 0.1829 mmol) in pyridine was added. The reaction was monitored by TLC to check the completion of the reaction (16 h). The reaction mixture was concentrated to remove pyridine. The reaction was quenched with aqueous 1 N HCl and extracted with DCM (2 × 20 mL). The product was purified by CC using n-hexane-EA (85:15) to give 15a-15h in good yields. 
(E)-4-(3-Methoxyprop-1-en-1-yl)phenyl 3-methylbut-2-enoate (15c)

4-((E)-3-Methoxyprop-1-en-1-yl)phenyl cinnamate
4-{(Tert-butyldimethylsilyl)oxy}benzaldehyde (16):
About 10 g of p-hydroxybenzaldehyde (11) was dissolved in 100 mL of dry DCM and to the stirred solution was added imidazole portion wise at 0°C. After being stirred for 20 min at 0°C, TBDMSCl was added and the mixture was stirred for 1 h at r.t. The reaction was completed in 1 h. Then the reaction mixture was quenched with cold water and the compound extracted with chloroform. The organic layer was washed with brine and dried over sodium sulfate. The organic layers were combined and evaporated in a rotary evaporator. The crude product was purified by silica gel CC using n-hexane: EtOAc (85:15) to give 16 [16] as a white crystalline solid (91%).
1-4-{(tert-butyldimethylsilyl)oxy}phenyl}prop-2-en-1-ol (17):
To a solution of 16 (10 g, 42.37 mmole) in dry THF (100 mL) under a nitrogen atmosphere at 0°C was added, dropwise, 50.48 mL of a 1M solution of magnesium bromide in THF. The reaction was allowed to stir for 45 min at r.t. After completion (TLC), the reaction was quenched with saturated NH 4 Cl solution at 0°C and extracted with ethyl acetate (2×50 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 and the solvent was evaporated to dryness. The crude product was purified by CC using Hex: EA (90:10) as eluent to give vinyl alcohol (17) [16] as light yellow viscous liquid.(60%).
4-(1-Hydroxyallyl) phenol (20):
To a stirred solution of 17 (2 g, 6.8 mmol) in LR grade THF at 0°C was added TBAF, dropwise, and the reaction was stirred for 1 h. The progress of the reaction was monitored by TLC. After completion (1 h), the reaction mixture was concentrated to remove THF and the oil was dissolved in EA and extracted with 1 N HCl (20 mL), washed with brine, dried over Na 2 SO 4 and concentrated. The product was purified by silica gel CC using n-hexane: EtOAc (90:10) to give 20 [16] as a yellow oily liquid (68%).
4-(1-Acetoxyallyl) phenyl acetate (21):
To a solution of 20 (1 g, 6.5 mmol) in DCM (10 mL), under a nitrogen atmosphere at r.t., was added, dropwise, triethylamine (2.32 mL, 16.392 mmol), followed by acetic anhydride (1.52 mL, 16.2 mmol). The reaction mixture Phenylpropanoids from Alpania galanga Natural Product Communications Vol. 8 (12) 2013 1745 was stirred for 1 h at 0°C. After completion (TLC), the reaction was quenched with ice at r.t., extracted with CHCl 3 (2× 25 mL), the combined organic layers washed with brine, dried over Na 2 SO 4 and the solvent evaporated to dryness. The crude product was purified by CC using Hex: EA (90:10) to give compound 21 [16] as a light yellow oily liquid (70%). 1-(4-{(Tert-butyldimethylsilyl)oxy}phenyl)prop-2-en-1-ol (18)  and  (1S)-(4-{(tert-butyldimethylsilyl)oxy}phenyl)(oxiran-2yl)methanol (19) : Completely evacuated, flame dried, powdered 4 Å molecular sieves (10 g) and (-)-DIPT (2.10 g, 9.38 mmol) were placed in a 250 mL two necked r.b flask and dissolved in dry DCM (40 mL). To the stirred mixture a solution of Ti (iOPr) 4 (2.22 g, 7.82 mmol) was added at -20°C, followed by (1.44 g, 9. 38 mmol) cumene hydroperoxide at an interval of 20 min. After being stirred for 20 min, a solution of compound 17 (4.12 g, 15.64 mmol) in DCM (10 mL) was added, dropwise. The reaction mixture was allowed to stir for 12 h. The reaction was monitored by TLC. After completion (12 h), the reaction was quenched by a solution containing 4 g of NaOH dissolved in 40 mL of saturated NaCl at 0°C. Stirring continued for 3 h at r.t. before the mixture was filtered through Celite and the filtrate concentrated. The product was purified by silica gel CC using n-hexane: EtOAc (90:10) to give 18 and n-hexane: EtOAc (75:25) to give 19. 
(S)-
(S)-4-(1-Hydroxyallyl) phenol (10):
To a stirred solution of compound 18 (2g, 6.8 mmol) in LR grade THF at 0°C was added TBAF, dropwise, and the reaction was stirred for 1 h. After completion of the reaction (TLC), the mixture was concentrated to remove THF, and the oil was dissolved in EA and extracted with 1 N HCl (20 mL), washed with brine, dried over Na 2 SO 4 and concentrated. The product was purified by silica gel CC using Nhexane: EtOAc (90:10) to give 10. 13 C NMR (75 MHz, CDCl 3 ): δ: 64.6 (CH), 106.4 (C), 113.6 (C), 119.1 (CH 2 ), 124.6 (CH), 148.5 (C).
(S)-4-(1-Acetoxyallyl)phenyl acetate (23):
To a stirred solution of compound 10 (0.05g, 0.33 mmol) in DCM (10 mL) under nitrogen at r.t. was added triethylamine (2.32 mL, 16.392 mmol), followed by acetic anhydride (51.48 mg, 0.39 mmol), dropwise. The reaction mixture was stirred for 1 h at 0°C. After completion (TLC), the reaction was quenched with ice at r.t. and extracted with CHCl 3 (2×10 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 and the solvent was evaporated to dryness. The crude product was purified by CC using Hex: EA (90:10) to give compound 23 [16] as a light yellow oily liquid (70%).
General procedure for the preparation of compounds 22a & 22b:
To a stirred solution of compound 10 (0.05 g, 0.33 mmol) in DCM (10 mL) under a nitrogen atmosphere at r.t. was added triethylamine (2.32 mL, 16.392 mmol).To this solution, acetic anhydride (51.48 mg, 0.39 mmol) was added, dropwise. The reaction mixture was allowed to stir for 30 min. at 0°C to achieve selective acylation of the phenolic OH. After completion (TLC), the reaction was quenched with ice at r.t. and extracted with CHCl 3 (2×10 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 and the solvent evaporated to dryness. The crude product was purified by CC using Hex: EA (90:10) to give compounds 22a and 22b. 
(S, Z)-4-(1-Hydroxyallyl)phenyl 2-methylbut-2-enoate (22c):
To a stirred solution of tiglic acid (1.09 mmol) in pyridine at 0°C, EDCI (140 mg, 0.35 mmol) and DMAP (4.45 mg, 0.036 mmol) were added. The reaction mixture was stirred at room temperature and, after complete dissolution of EDC, a solution of compound 10 (0.04 g, 0.1829 mmol) in pyridine was added. The reaction was allowed to stir for 16 h and then the mixture was concentrated to remove pyridine. The reaction was quenched with aqueous 1 N HCl and extracted with DCM (2 × 20 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 
